Riskpilot← Back to searchSign inGet full accessC. and Create AB
ABActiveOrg 5568887045Stortorget 7-9Medical specialists activities · NACE 8622Est. 201210-19 employees
Revenue 2024
SEK 25,4M
-18% vs 2023
EBITDA margin
-4.6%
-124% vs 2023
Equity ratio
36.0%
Financial strength
Net profit 2024
SEK -212K
-109% vs 2023
| Revenue | SEK 25,4M | -18% |
| EBITDA | SEK -1,2M | -124% |
| Net profit | SEK -212K | -109% |
| Total assets | SEK 12,5M | -30% |
| Equity | SEK 4,5M | -23% |
| Employees | — | — |
Legal name
C. and Create AB
Org number
5568887045
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
26 mars 2012
Share capital
SEK 50 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bolaget är en komplett specialistklinik med kunskap inom både estetiska såväl som rekonstruktiva plastikkirurgiska ingrepp och behandlingar. Bolaget bedriver medicinska och kirurgiska behandlingar, konsultationer samt försäljning av medicinska artiklar.
Address
Stortorget 7-9
Email
chrisjanbaz@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 760 | 9 708 | 16 059 | 27 434 | 38 466 | 31 015 | 25 350 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −3 | — | 0 | −975 | 2 838 | 4 051 | 2 270 | 7 674 | 4 796 | −1 158 |
| Depreciation & amort. | −0 | −0 | — | −99 | −336 | −366 | −587 | −716 | −676 | −336 |
| EBIT | −3 | 0 | 0 | −1 074 | 2 502 | 3 685 | 1 683 | 6 958 | 4 120 | −1 494 |
| Net financials | — | — | — | — | −3 | −22 | −324 | −368 | −2 505 | −2 215 |
| Profit before tax | −3 | 0 | 0 | −1 074 | 2 009 | 2 663 | 1 218 | 4 865 | 3 145 | 18 |
| Tax | −0 | −0 | — | −0 | −209 | −572 | −262 | −950 | −868 | −230 |
| Net profit | −3 | 0 | — | −1 074 | 1 800 | 2 091 | 956 | 3 915 | 2 277 | −212 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 39 | 39 | — | 2 646 | 6 828 | 8 193 | 15 272 | 19 349 | 17 869 | 12 479 |
| Equity | 39 | 0 | — | 165 | 1 965 | 2 256 | 2 211 | 5 127 | 5 803 | 4 491 |
| Long-term debt | 0 | 0 | — | 2 253 | 1 648 | 18 | 5 354 | 4 668 | 3 567 | 2 695 |
| Short-term debt | 0 | 0 | — | 229 | 2 724 | 4 429 | 6 074 | 6 197 | 5 672 | 5 292 |
| Total debt | — | — | — | 2 482 | 4 372 | 4 447 | 11 428 | 10 865 | 9 239 | 7 987 |
EBITDA margin
-4.6%
This company
15.8%
Market median
-129% vs market
20152024
Equity ratio
36.0%
This company
38.2%
Market median
+6% vs market
20152024
Return on equity
-4.7%
This company
18.4%
Market median
-126% vs market
20152024
Net profit margin
-0.8%
This company
8.1%
Market median
-110% vs market
20152024
Asset turnover
2.03×
This company
1.12×
Market median
+81% vs market
20152024
Debt / equity
1.78×
This company
0.62×
Market median
-187% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TE Audit | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of C. and Create AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Terje Eggen | Audit | 0 companies |
| Linda Johanna Margareta Janbaz | Deputy Board Member | 0 companies |
| Chris Conrad Diamond Janbaz | Board of Directors | 0 companies |
| Linda Johanna Margareta Janbaz | Deputy Board Member | 0 companies |